| Product Code: ETC9966854 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Generalized Anxiety Disorder Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Generalized Anxiety Disorder Market - Industry Life Cycle |
3.4 United States (US) Generalized Anxiety Disorder Market - Porter's Five Forces |
3.5 United States (US) Generalized Anxiety Disorder Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.6 United States (US) Generalized Anxiety Disorder Market Revenues & Volume Share, By Therapies, 2021 & 2031F |
3.7 United States (US) Generalized Anxiety Disorder Market Revenues & Volume Share, By Devices, 2021 & 2031F |
4 United States (US) Generalized Anxiety Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of mental health issues in the US |
4.2.2 Growing prevalence of generalized anxiety disorder in the US population |
4.2.3 Advances in pharmacological and non-pharmacological treatment options for generalized anxiety disorder |
4.3 Market Restraints |
4.3.1 Stigma associated with mental health disorders leading to underreporting and underdiagnosis |
4.3.2 High cost of treatment and therapy for generalized anxiety disorder |
4.3.3 Limited access to mental health services and professionals in certain regions of the US |
5 United States (US) Generalized Anxiety Disorder Market Trends |
6 United States (US) Generalized Anxiety Disorder Market, By Types |
6.1 United States (US) Generalized Anxiety Disorder Market, By Therapeutics |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.3 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Antidepressant, 2021- 2031F |
6.1.4 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Buspirone, 2021- 2031F |
6.1.5 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.1.6 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Generalized Anxiety Disorder Market, By Therapies |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Interpersonal Therapy, 2021- 2031F |
6.2.3 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Behavior Therapy, 2021- 2031F |
6.2.4 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Cognitive Behavioral Therapy, 2021- 2031F |
6.2.5 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Mindfulness Based Cognitive Therapy, 2021- 2031F |
6.3 United States (US) Generalized Anxiety Disorder Market, By Devices |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Deep Brain Stimulation, 2021- 2031F |
6.3.3 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Electroconvulsive Therapy, 2021- 2031F |
6.3.4 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.3.5 United States (US) Generalized Anxiety Disorder Market Revenues & Volume, By Vagus Nerve Stimulation, 2021- 2031F |
7 United States (US) Generalized Anxiety Disorder Market Import-Export Trade Statistics |
7.1 United States (US) Generalized Anxiety Disorder Market Export to Major Countries |
7.2 United States (US) Generalized Anxiety Disorder Market Imports from Major Countries |
8 United States (US) Generalized Anxiety Disorder Market Key Performance Indicators |
8.1 Number of individuals seeking treatment for generalized anxiety disorder |
8.2 Percentage of healthcare providers incorporating mental health screenings in routine care |
8.3 Adoption rate of new therapies and treatment modalities for generalized anxiety disorder |
9 United States (US) Generalized Anxiety Disorder Market - Opportunity Assessment |
9.1 United States (US) Generalized Anxiety Disorder Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.2 United States (US) Generalized Anxiety Disorder Market Opportunity Assessment, By Therapies, 2021 & 2031F |
9.3 United States (US) Generalized Anxiety Disorder Market Opportunity Assessment, By Devices, 2021 & 2031F |
10 United States (US) Generalized Anxiety Disorder Market - Competitive Landscape |
10.1 United States (US) Generalized Anxiety Disorder Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Generalized Anxiety Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here